Arena Pharmaceuticals Gets FDA's OK For Obesity Drug

Published on by topnewsrom

 

(By Rich Bieglmeier) Arena Pharmaceuticals, Inc. (ARNA) obesity drug, now called Belviq (formerly known as lorcaserin) has been Okayed by an 18-4 vote. It is the first new obesity drug to hit the market in 13 years. The stock

(HALTED). Written on June 27, 2012 by gem-x in Elliott Wave Intraday – 12:23 pm. http://finance.yahoo.com/news/arena-pharmaceuticals-confirms-fda-approval-171615365.html. 0 Comments – Leave a comment! – - 12:23 pm

News that the Food & Drug Administration has approved Arena Pharmaceuticals (NASDAQ: ARNA ) weight-loss pill Lorcaserin is proving.

News that the Food & Drug Administration has approved Arena Pharmaceuticals (NASDAQ: ARNA ) weight-loss pill Lorcaserin is proving.

more:

Arena Pharmaceuticals Gets FDA's OK For Obesity Drug

Related Posts:

 

Published on News

Share this post

Comment on this post